- Home
- DNLI vs USA Comparison
DNLI vs USA Comparison
Compare DNLI & USA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- USA
- Stock Information
- Founded
- DNLI 2013
- USA 1986
- Country
- DNLI United States
- USA United States
- Employees
- DNLI N/A
- USA N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- USA Finance Companies
- Sector
- DNLI Health Care
- USA Finance
- Exchange
- DNLI Nasdaq
- USA Nasdaq
- Market Cap
- DNLI 2.3B
- USA 1.9B
- IPO Year
- DNLI 2017
- USA N/A
- Fundamental
- Price
- DNLI $15.21
- USA N/A
- Analyst Decision
- DNLI Strong Buy
- USA
- Analyst Count
- DNLI 15
- USA 0
- Target Price
- DNLI $33.50
- USA N/A
- AVG Volume (30 Days)
- DNLI 2.0M
- USA 880.5K
- Earning Date
- DNLI 11-05-2025
- USA 01-01-0001
- Dividend Yield
- DNLI N/A
- USA 9.66%
- EPS Growth
- DNLI N/A
- USA N/A
- EPS
- DNLI N/A
- USA N/A
- Revenue
- DNLI N/A
- USA N/A
- Revenue This Year
- DNLI N/A
- USA N/A
- Revenue Next Year
- DNLI $95,463.19
- USA N/A
- P/E Ratio
- DNLI N/A
- USA N/A
- Revenue Growth
- DNLI N/A
- USA N/A
- 52 Week Low
- DNLI $10.57
- USA $5.62
- 52 Week High
- DNLI $33.33
- USA $7.09
- Technical
- Relative Strength Index (RSI)
- DNLI 54.76
- USA 36.78
- Support Level
- DNLI $15.03
- USA $6.18
- Resistance Level
- DNLI $16.51
- USA $6.56
- Average True Range (ATR)
- DNLI 0.80
- USA 0.08
- MACD
- DNLI 0.11
- USA -0.01
- Stochastic Oscillator
- DNLI 61.42
- USA 32.76
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About USA Liberty All-Star Equity Fund
Liberty All Star Equity Fund is a multi-managed fund. Its objective is to provide a high level of current income and long-term capital appreciation through investing principally in a diversified portfolio of equity securities. The fund invests in various sectors, including financials, information technology, healthcare, consumer discretionary, consumer staples, industrials, energy, materials, real estate, utilities, telecommunication, and other services.